SCHEMBL4040310

SCHEMBL4040310

O=C(NC1CCCCC1)C(C1CCCCC1)C1(c2ccccn2)Nc2cc(F)c(F)cc2N1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 1/20 0.41
ERBB2 P04626 1/20 0.41
MET P08581 1/20 0.41
KDR P35968 1/20 0.41
MERTK Q12866 1/20 0.41
KMT2A Q03164 4/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
MEN1 O00255 2/20 0.40
EPHX2 P34913 1/20 0.38
KDM4E B2RXH2 2/20 0.38
C3AR1 Q16581 1/20 0.38
ALDH1A1 P00352 3/20 0.38
IDO1 P14902 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
LMNA P02545 2/20 0.37
MAPT P10636 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4041039 0.93 CYP3A4 (0.41) EGFRERBB2METKDRMERTK
SCHEMBL4035291 0.91 EGFR (0.42) EGFRERBB2METKDRMERTK
SCHEMBL4034809 0.91 IDO1 (0.42) EGFRERBB2METKDRMERTK
SCHEMBL2915028 0.82 KMT2A (0.43) EGFRERBB2METKDRMERTK
SCHEMBL4038088 0.80 RAB9A (0.44) KMT2ANPC1RAB9AMEN1SMN1; SMN2
SCHEMBL4038304 0.80 RAB9A (0.44) KMT2ANPC1RAB9AMEN1SMN1; SMN2
SCHEMBL3650434 0.78 KMT2A (0.41) KMT2ANPC1RAB9AMEN1ALDH1A1
SCHEMBL4040844 0.78 NR1H4 (0.47) NPC1RAB9AEPHX2ALDH1A1SMN1; SMN2
SCHEMBL4040697 0.78 NPC1 (0.44) KMT2ANPC1RAB9AMEN1EPHX2
SCHEMBL4035029 0.78 NR1H4 (0.47) NPC1RAB9AEPHX2ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2038259-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F.HOFFMANN-LA ROCHE AG (CH) 2009-03-25 EP claimed
WO-2008000643-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F. HOFFMANN-LA ROCHE AG (CH) 2008-01-03 WO claimed
EP-3043865-A1 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTION Institut National de la Santé et de la Recherche Médicale (INSERM) (FR) 2016-07-20 EP disclosed
WO-2015036442-A1 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTION INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2015-03-19 WO disclosed
EP-2038259-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F.HOFFMANN-LA ROCHE AG (CH) 2009-03-25 EP disclosed
WO-2008000643-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F. HOFFMANN-LA ROCHE AG (CH) 2008-01-03 WO disclosed